Stay updated on Nivolumab Ipilimumab SBRT in Salivary Gland Cancers Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Ipilimumab SBRT in Salivary Gland Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Ipilimumab SBRT in Salivary Gland Cancers Clinical Trial page

  1. Check
    8 days ago
    No Change Detected
  2. Check
    15 days ago
    Change Detected
    Summary
    Added a Locations section with Washington as a study location and removed the prior Washington Locations item. Also updated the page revision from v3.3.2 to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T09:25:26.000Z thumbnail image
  3. Check
    23 days ago
    No Change Detected
  4. Check
    37 days ago
    Change Detected
    Summary
    Page shows a minor version update from v3.3.1 to v3.3.2; no changes to study details, layout, or user-facing content are evident. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T16:45:24.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    Revision: v3.3.1 is now shown, replacing the previous Revision: v3.2.0. The study details, eligibility criteria, and results remain unchanged.
    Difference
    0.1%
    Check dated 2025-11-24T13:27:51.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The government funding lapse notice was removed from the page.
    Difference
    0.4%
    Check dated 2025-11-17T06:28:39.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The screenshots show cosmetic formatting updates and minor textual edits that do not modify the study's core details (interventions, eligibility, endpoints, or enrollment). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T01:08:20.000Z thumbnail image
  8. Check
    94 days ago
    Change Detected
    Summary
    Summary: The page adds a government-operating-status notice and a v3.2.0 release tag, while removing the v3.1.0 tag. The new notice is the significant change, signaling updated operating status and potential transaction delays.
    Difference
    2%
    Check dated 2025-10-05T10:03:54.000Z thumbnail image

Stay in the know with updates to Nivolumab Ipilimumab SBRT in Salivary Gland Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Ipilimumab SBRT in Salivary Gland Cancers Clinical Trial page.